HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Hepion Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.10−0.00 (-1.45%)
Close on Oct 19, 2026
- Market cap
- $1.65M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Hepion Pharmaceuticals has not reported a dividend
No dividend per share appears in Hepion Pharmaceuticals's annual filings since fiscal 2013.